169 related articles for article (PubMed ID: 35528004)
1. A Prognostic Model of Differentiated Thyroid Cancer Based on Up-Regulated Glycolysis-Related Genes.
Wu M; Ou-Yang DJ; Wei B; Chen P; Shi QM; Tan HL; Huang BQ; Liu M; Qin ZE; Li N; Hu HY; Huang P; Chang S
Front Endocrinol (Lausanne); 2022; 13():775278. PubMed ID: 35528004
[TBL] [Abstract][Full Text] [Related]
2. Identification of a glycolysis-related gene signature for survival prediction of ovarian cancer patients.
Zhang D; Li Y; Yang S; Wang M; Yao J; Zheng Y; Deng Y; Li N; Wei B; Wu Y; Zhai Z; Dai Z; Kang H
Cancer Med; 2021 Nov; 10(22):8222-8237. PubMed ID: 34609082
[TBL] [Abstract][Full Text] [Related]
3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
4. A Comprehensive Prognostic and Immunological Analysis of a Six-Gene Signature Associated With Glycolysis and Immune Response in Uveal Melanoma.
Liu J; Lu J; Li W
Front Immunol; 2021; 12():738068. PubMed ID: 34630418
[TBL] [Abstract][Full Text] [Related]
5. Identification and Validation of a Novel Glycolysis-Related Gene Signature for Predicting the Prognosis and Therapeutic Response in Triple-Negative Breast Cancer.
Zheng J; Zhang YF; Han GH; Fan MY; Du MH; Zhang GC; Zhang B; Qiao J; Zhang SX; Cao JM
Adv Ther; 2023 Jan; 40(1):310-330. PubMed ID: 36316558
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of a Prognostic Signature Based on Methylation Profiles and Methylation-Driven Gene
Ju G; Zhang L; Guo W; Wang H; Zhang X; Mu Z; Sun Y; Sun D; Diao H; Miao S; Chen Y; Xing T; Liang J; Lin Y
Dis Markers; 2022; 2022():1686316. PubMed ID: 37223105
[TBL] [Abstract][Full Text] [Related]
7. Identification of a glycolysis-related gene signature for predicting prognosis in patients with hepatocellular carcinoma.
Kong J; Yu G; Si W; Li G; Chai J; Liu Y; Liu J
BMC Cancer; 2022 Feb; 22(1):142. PubMed ID: 35123420
[TBL] [Abstract][Full Text] [Related]
8. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
9. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Recurrence Signature and Validation of Cell Infiltration Level of Thyroid Cancer Microenvironment.
Zhang L; Wang Y; Li X; Wang Y; Wu K; Wu J; Liu Y
Front Endocrinol (Lausanne); 2020; 11():467. PubMed ID: 32793117
[TBL] [Abstract][Full Text] [Related]
11. A Metabolic-associated Nomogram Predicts Recurrence Survival of Thyroid Cancer.
Xi ZH; Ma XX; Chen HY; Yu YH; Li L; Huang T
Curr Med Sci; 2021 Oct; 41(5):1004-1011. PubMed ID: 34510328
[TBL] [Abstract][Full Text] [Related]
12. Identification of ferroptosis genes in immune infiltration and prognosis in thyroid papillary carcinoma using network analysis.
Lin R; Fogarty CE; Ma B; Li H; Ni G; Liu X; Yuan J; Wang T
BMC Genomics; 2021 Jul; 22(1):576. PubMed ID: 34315405
[TBL] [Abstract][Full Text] [Related]
13. A seven-autophagy-related gene signature for predicting the prognosis of differentiated thyroid carcinoma.
Li C; Yuan Q; Xu G; Yang Q; Hou J; Zheng L; Wu G
World J Surg Oncol; 2022 Apr; 20(1):129. PubMed ID: 35459137
[TBL] [Abstract][Full Text] [Related]
14. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
15. Effects of Glycolysis-Related Genes on Prognosis and the Tumor Microenvironment of Hepatocellular Carcinoma.
Zheng JY; Liu JY; Zhu T; Liu C; Gao Y; Dai WT; Zhuo W; Mao XY; He BM; Liu ZQ
Front Pharmacol; 2022; 13():895608. PubMed ID: 35924040
[No Abstract] [Full Text] [Related]
16. A Novel Immune-Related Prognostic Signature for Thyroid Carcinoma.
Xue Y; Li J; Lu X
Technol Cancer Res Treat; 2020; 19():1533033820935860. PubMed ID: 32588760
[TBL] [Abstract][Full Text] [Related]
17. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
18. A methylomics-associated nomogram predicts recurrence-free survival of thyroid papillary carcinoma.
Chen H; Ma X; Yang M; Wang M; Li L; Huang T
Cancer Med; 2020 Oct; 9(19):7183-7193. PubMed ID: 32783399
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of an Inflammatory Response-Related Gene Signature for Predicting the Prognosis of Pancreatic Adenocarcinoma.
Deng ZL; Zhou DZ; Cao SJ; Li Q; Zhang JF; Xie H
Inflammation; 2022 Aug; 45(4):1732-1751. PubMed ID: 35322324
[TBL] [Abstract][Full Text] [Related]
20. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]